Cover Image
市場調查報告書

美國的再生醫療市場:2017年∼2021年

Regenerative Medicine Market in the US 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 277867
出版日期 內容資訊 英文 107 Pages
訂單完成後即時交付
價格
Back to Top
美國的再生醫療市場:2017年∼2021年 Regenerative Medicine Market in the US 2017-2021
出版日期: 2017年07月26日 內容資訊: 英文 107 Pages
簡介

再生醫療是為了治療人體細胞、組織,以及內臟器官,治療用誘導,或處理在研究室培養的人體組織利用的流程。作為治療疾病和受傷的媒體,沒有正常的作用,及幫助取代損傷細胞產生新的細胞,新的治療領域。預期利用在多樣的疾病治療中,美國的再生醫療市場,預計在2017-2021年期間以23.53%的年複合成長率 (CAGR) 成長。

本報告以美國的再生醫療市場為研究主題,提供基因治療及市場概要,開發中產品狀況,法規情形,市場發展推動因素,市場上的課題,和那些的影響,各產品、各用途的市場現況與展望相關調查分析,主要的供應商簡介彙整。

第1章 摘要整理

第2章 調查範圍

第3章 市場調查手法

第4章 簡介

  • 美國市場的再生醫療

第5章 市場形勢

  • 市場概要
  • 市場規模、預測

第6章 產品研發線

  • 波特的五力分析

第7章 市場區隔:各產品

  • 美國的細胞治療市場
  • 美國的支架市場

第8章 市場區隔:各用途

  • 皮膚科學
  • 肌肉骨骼系統
  • 眼球
  • 心血管

第9章 市場區隔:各終端用戶

  • 醫院
  • 門診外科中心(ASC)
  • 再生醫療中心

第10章 決策結構

第11章 市場發展推動因素與課題

第12章 市場趨勢

第13章 業者情勢

  • 競爭模式

第14章 主要供應商分析

  • Acelity
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • Zimmer Biomet
  • 其他主要供應商

第15章 附錄

  • 簡稱集

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR13871

About Regenerative Medicine Market in the US

Regenerative medicine is a bioproduct, which is developed by using translational research techniques such as molecular biology, tissue engineering, and gene engineering. Stem cells and tissue scaffolds have the effective therapeutic potential, which has increased the adoption of regenerative medicine in the US market. Stem cell therapy responds well to various treatments such as dermatological, macular, musculoskeletal, and cardiovascular applications. The regenerative medicine industry includes four key sectors, which help the vendors to develop regenerative medicine.

Technavio's analysts forecast the Regenerative Medicine Market in the US to grow at a CAGR of 23.53% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the Regenerative Medicine Market in the US for 2017-2021. To calculate the market size, the report considers the sales, volume, and value of regenerative medicine market in the US.

Technavio's report, Regenerative Medicine Market in the US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Acelity
  • Medtronic
  • MiMedx
  • Organogenesis
  • Zimmer Biomet

Other Prominent Vendors

  • ACE Surgical Supply
  • Acera Surgical
  • Acologix
  • Advanced Biologics
  • AlloCure
  • AlloSource
  • Alphatec Spine
  • ANTEROGEN
  • Antibe Therapeutics
  • Astellas Pharma
  • Athersys
  • Avita Medical
  • AxoGen
  • Bacterin International
  • Baxter
  • Bellicum Pharmaceuticals
  • BioCardia
  • Biogen
  • BioRestorative Therapies
  • Biostage
  • Bio-Tissue
  • BioTissue
  • bluebird bio
  • BONESUPPORT
  • BrainStorm Cell Therapeutics
  • Caladrius
  • Calimmune
  • Capricor Therapeutics
  • CELGENE
  • Cell Medica
  • Cell Therapy
  • CellBioMed
  • CellSeed
  • Celyad
  • CESCA THERAPEUTICS
  • CTM CRC
  • CryoLife
  • Cynata
  • Cytori Therapeutics
  • Dendreon Pharmaceuticals
  • DiscGenics
  • Fate Therapeutics
  • Fibrocell Science
  • Forticell Bioscience
  • Fortress Biotech
  • FUJIFILM Holdings
  • Gamida Cell
  • Geron
  • GlaxoSmithKline
  • Healthpoint (acquired by Smith & Nephew)
  • Histogen
  • Histogenics
  • Holostem Terapie Avanzate
  • Humacyte
  • Immunocellular Therapeutics
  • Integra LifeSciences
  • Intercytex
  • InVivo Therapeutics
  • iSTO Biologics
  • Janssen Pharmaceuticals
  • Juno Therapeutics
  • Juventas Therapeutics
  • Kiadis Pharma
  • LifeCell
  • LifeNet Health
  • Living Cell Technologies
  • Lonza
  • MaxCyte
  • MEDIPOST
  • Mesoblast
  • Nanofiber Solutions
  • Nanotope
  • Neuralstem
  • NewLink Genetics
  • Northwest Biotherapeutics
  • NovaRx
  • Opexa Therapeutics
  • ORGANOVO HOLDINGS
  • Orteq
  • Orthofix Holdings
  • Osiris Therapeutics
  • Pfizer
  • PHARMICELL
  • Pluristem
  • Prima BioMed
  • Q Therapeutics
  • Regenerex
  • Regenerys
  • Regience
  • Regrow
  • RENOVA THERAPEUTICS
  • RepliCel
  • ReproCELL
  • RhinoCyte
  • Rohto Pharma
  • RTI Surgical
  • SanBio
  • Sangamo Therapeutics
  • Shanghai Sunway Biotech
  • Shire
  • Stratatech
  • SURGILOGIX
  • Synergistic Technologies
  • TAKARA BIO
  • tella
  • Tissue Genesis
  • TissueGene
  • Txcell
  • VentriNova
  • Vericel
  • ViaCyte
  • VistaGen Therapeutics

Market driver

  • CVD and diabetes in young adult and aging population
  • For a full, detailed list, view our report

Market challenge

  • High cost of clinical trial
  • For a full, detailed list, view our report

Market trend

  • Increasing strategic alliances
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Overview of regenerative medicine in the US market

PART 05: Market landscape

  • Market overview
  • Market size and forecast

PART 06: Pipeline portfolio

  • Five forces analysis

PART 07: Market segmentation by product

  • Cell therapy market in US
  • Tissue scaffolds market in US

PART 08: Market segmentation by application

  • Dermatological
  • Musculoskeletal
  • Ocular
  • Cardiovascular

PART 09: Market segmentation by end-user

  • Hospitals
  • ASCs
  • Regenerative medicine centers

PART 10: Decision framework

PART 11: Drivers and challenges

  • Market drivers
  • Market challenges

PART 12: Market trends

  • Increasing strategic alliances
  • Increasing number of regenerative medicine in product line
  • Gene therapy trending toward market expansion

PART 13: Vendor landscape

  • Competitive landscape

PART 14: Key vendor analysis

  • Acelity
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • Zimmer Biomet
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Overview of key sectors involved in regenerative medicine
  • Exhibit 02: SBIR and STTR programs
  • Exhibit 03: Regenerative medicine market in US 2016-2021 ($ billions)
  • Exhibit 04: Pipeline of regenerative medicines for CVDs
  • Exhibit 05: Pipeline of regenerative medicines for central nervous system, orthopedic, and ocular disorders
  • Exhibit 06: Pipeline of regenerative medicines for dermatology and diabetes
  • Exhibit 07: Pipeline of regenerative medicines for oncology
  • Exhibit 08: Five forces analysis
  • Exhibit 09: Regenerative medicine market in US by product
  • Exhibit 10: Regenerative medicine market in US by product 2016 and 2021 ($ billions)
  • Exhibit 11: Ethical issues involved in different cell therapy research categories
  • Exhibit 12: Key cell therapy products marketed in US
  • Exhibit 13: Cell therapy market in US 2016-2021 ($ billions)
  • Exhibit 14: Market dynamics: Cell therapy market in US
  • Exhibit 15: Collaborations for R&D of tissue scaffold
  • Exhibit 16: Tissue scaffolds market in US 2016-2021 ($ millions)
  • Exhibit 17: Recent M&A in tissue scaffolds market
  • Exhibit 18: Market dynamics: Tissue scaffolds market in US
  • Exhibit 19: Regenerative medicine market in US by application 2016 (%)
  • Exhibit 20: Market growth: Regenerative medicine market in US by application
  • Exhibit 21: Overview of dermatological in regenerative medicine market in US
  • Exhibit 22: Target population and market growth opportunity
  • Exhibit 23: Pipeline of regenerative medicine for dermatological
  • Exhibit 24: Overview of musculoskeletal in regenerative medicine market in US
  • Exhibit 25: Regenerative medicine for occupational injury and sports injury
  • Exhibit 26: Pipeline of regenerative medicine for musculoskeletal
  • Exhibit 27: Overview of ocular in regenerative medicine market in US
  • Exhibit 28: Market overview of CVDs in US
  • Exhibit 29: Overview of cardiovascular in regenerative medicine market in US
  • Exhibit 30: Regenerative medicine market in US by end-users 2016
  • Exhibit 31: Segmentation of hospitals based on number of beds
  • Exhibit 32: Revenues funded by federal agencies for regenerative medicine research in 2014 ($ millions)
  • Exhibit 33: Estimated budget of funding for research in regenerative medicines 2012-2017 ($ millions)
  • Exhibit 34: Regulatory challenges in regenerative product market
  • Exhibit 35: Major strategic alliances in regenerative medicine market globally
  • Exhibit 36: Some of the mid and late stage pipeline products for regenerative medicine
  • Exhibit 37: Competitive structure analysis of regenerative medicine market in US 2016
  • Exhibit 38: Competitive landscape of regenerative medicine market in US 2016
  • Exhibit 39: Strategies for large and small companies in regenerative medicine market in US
  • Exhibit 40: Key recommendations for new entrants in regenerative medicine market in US
  • Exhibit 41: Acelity: Key highlights
  • Exhibit 42: Acelity: Strength assessment
  • Exhibit 43: Acelity: Strategy assessment
  • Exhibit 44: Acelity: Opportunity assessment
  • Exhibit 45: Medtronic: Key highlights
  • Exhibit 46: Medtronic: Strength assessment
  • Exhibit 47: Medtronic: Strategy assessment
  • Exhibit 48: Medtronic: Opportunity assessment
  • Exhibit 49: MiMedx Group: Key highlights
  • Exhibit 50: MiMedx Group: Strength assessment
  • Exhibit 51: MiMedx Group: Strategy assessment
  • Exhibit 52: MiMedx Group: Opportunity assessment
  • Exhibit 53: Organogenesis: Key highlights
  • Exhibit 54: Organogenesis: Strength assessment
  • Exhibit 55: Organogenesis: Strategy assessment
  • Exhibit 56: Organogenesis: Opportunity assessment
  • Exhibit 57: Zimmer Biomet: Key highlights
  • Exhibit 58: Zimmer Biomet: Strength assessment
  • Exhibit 59: Zimmer Biomet: Strategy assessment
  • Exhibit 60: Zimmer Biomet: Opportunity assessment
  • Exhibit 61: Other prominent vendors: Regenerative medicine market in US
Back to Top